Gastroesophageal Reflux Disease

🏷

Classifications

Harrison's Part

C

Comorbidities

Hypermobile Ehlers-Danlos Syndrome <-> Gastroesophageal Reflux Disease

Obesity <-> Gastroesophageal Reflux Disease

⚙

Pathophysiology

8

Lower Esophageal Sphincter Dysfunction

Transient relaxations or chronic hypotension of the LES allow retrograde flow of gastric contents into the esophagus. Hiatal hernia exacerbates sphincter incompetence.

Smooth Muscle Contraction GO:0006939

Lower Esophageal Sphincter UBERON:0004550

Show evidence (2 references)

PMID:38177402 SUPPORT

"GERD starts in the stomach, where the refluxate material is produced. Following the trajectory of reflux, the failure of the antireflux barrier, primarily the lower oesophageal sphincter and the crural diaphragm, enables the refluxate to reach the oesophageal lumen, triggering oesophageal or..."

This review describes the failure of the antireflux barrier, particularly the lower esophageal sphincter, as a core mechanism allowing refluxate to enter the esophagus and cause symptoms.

PMID:38177402 SUPPORT

"Alterations of the oesophageal mucosal integrity, such as macroscopic oesophagitis or microscopic changes, determine the perception of symptoms."

Supports symptom effects of mucosal injury in GERD, but only indirectly supports LES dysfunction specifically.

Tight Junction Protein Loss

Tight junction proteins including claudins (1, 3, 4, 18), ZO-1, and occludin are decreased in GERD patient biopsies, as is the Na+,K+-ATPase β1 subunit that supports their assembly. Loss of these apical junctional complex proteins is what produces the increased paracellular permeability of the esophageal squamous epithelium.

Esophageal Epithelial Cell CL:0002252

Tight junction organization GO:0120193 ↓ DECREASED

Na+,K+-ATPase beta1 subunit activity GO:0005391 ↓ DECREASED

Esophageal Epithelium UBERON:0001976

Downstream

Dilated Intercellular Spaces Loss of apical junctional complex proteins increases paracellular permeability and widens the intercellular space of the squamous epithelium.

Show evidence (1 reference)

PMID:42562993 SUPPORT Human Clinical

"We found that tight junction proteins and the Na+,K+-ATPase β1 subunit were decreased in biopsies from patients with GERD."

Patient biopsy analysis directly demonstrates decreased tight junction protein expression and Na+,K+-ATPase β1 reduction in GERD.

Dilated Intercellular Spaces

Dilated intercellular spaces (DIS) are the histological consequence of junctional protein loss and are an early feature of both erosive and nonerosive GERD. The widened space lets acid and bile refluxate penetrate deeper into the esophageal epithelium.

Esophageal Epithelium UBERON:0001976

Downstream

Esophageal Mucosal Injury Reflux constituents reaching the widened intercellular space injure the cells and drive inflammation and tissue repair.

Show evidence (1 reference)

PMID:42562993 SUPPORT Other

"Dilated intercellular space (DIS) is a hallmark pathological feature of the esophageal squamous epithelium in individuals with GERD."

Establishes DIS as a defining pathological feature of GERD. The sentence opens the paper's introduction and carries citation marker [9], so it is background attributed to an earlier study rather than a result of this paper.

Esophageal Mucosal Injury

Gastric acid and pepsin damage esophageal epithelium, causing inflammation and erosions. Bile reflux in some patients adds to mucosal damage.

Esophageal Epithelial Cell CL:0002252

Esophageal Mucosa UBERON:0002469

Show evidence (2 references)

PMID:38177402 SUPPORT

"Alterations of the oesophageal mucosal integrity, such as macroscopic oesophagitis or microscopic changes, determine the perception of symptoms."

This documents that refluxate exposure produces esophageal mucosal injury in GERD, ranging from macroscopic esophagitis to microscopic changes.

PMID:38177402 SUPPORT

"It is now recognized that different GERD phenotypes have different degrees of reflux, severity of mucosal integrity damage and type, and severity of symptoms."

This review recognizes that mucosal integrity damage varies across GERD phenotypes and contributes to symptom severity.

Impaired Esophageal Clearance

Reduced salivary neutralization, impaired peristalsis, and delayed acid clearance prolong mucosal exposure to refluxate.

Digestion GO:0007586

Esophagus UBERON:0001043

Show evidence (1 reference)

PMID:38177402 SUPPORT

"Reflux clearance mechanisms such as primary and secondary peristalsis and the arrival of bicarbonate-rich saliva are critical to prevent mucosal damage."

This directly supports the role of impaired clearance mechanisms in prolonging refluxate exposure and increasing mucosal damage in GERD.

Visceral Hypersensitivity

Some patients experience symptoms with minimal acid exposure due to heightened esophageal sensory perception.

Show evidence (1 reference)

PMID:38177402 SUPPORT

"The intensity of the symptoms is affected by peripheral and central neural and psychological mechanisms."

This describes how neural mechanisms, including visceral hypersensitivity, affect symptom intensity in GERD patients even with varying degrees of acid exposure.

Gut Microbiota Dysbiosis

Altered gut microbiota composition contributes to GERD risk through bidirectional causal relationships. Protective taxa include Actinobacteria and Methanobrevibacter, while risk taxa include Mollicutes and Tenericutes.

Stomach UBERON:0000945

Show evidence (2 references)

PMID:38449873 SUPPORT

"The IVW method's findings suggested protective roles against GERD for the Family Clostridiales Vadin BB60 group (P = 0.027), Genus Lachnospiraceae UCG004 (P = 0.026), Genus Methanobrevibacter (P = 0.026), and Phylum Actinobacteria (P = 0.019). In contrast, Class Mollicutes (P = 0.037), Genus..."

This Mendelian randomization analysis suggests causal relationships between specific gut microbiota taxa and GERD risk, identifying both potentially protective and risk-associated groups.

PMID:38449873 SUPPORT

"For the first time, the MR analysis indicates a genetic link between gut microbiota abundance changes and GERD risk. This not only substantiates the potential of intestinal microecological therapy for GERD, but also establishes a basis for advanced research into the role of intestinal microbiota..."

This indicates a genetic link between gut microbiota abundance and GERD risk and motivates further study of microbiome-targeted therapeutic approaches.

Barrett's Esophagus Metaplastic Adaptation

Chronic reflux-induced inflammation drives metaplastic transformation of esophageal squamous epithelium to specialized columnar epithelium with altered tight junction protein expression, particularly claudin-18, which contributes to acid resistance.

Esophageal Epithelium UBERON:0001976

Show evidence (3 references)

PMID:17932229 SUPPORT

"In SCE, Cldn-18 was the most highly expressed at the mRNA level and this finding is paralleled by marked elevation in protein expression on immunoblots. In contrast in SqE, Cldn-18 was minimally expressed at the mRNA level and undetectable at the protein level."

This demonstrates that Barrett's esophagus exhibits a dramatic shift in tight junction protein composition, with claudin-18 becoming the dominant protein in metaplastic epithelium.

PMID:17932229 SUPPORT

"We conclude that Cldn-18 is the dominant claudin in the TJ of SCE and propose that the change from a Cldn-18-deficient TJ in SqE to a Cldn-18-rich TJ in SCE contributes to the greater acid resistance of BE."

This establishes that the claudin-18-rich tight junctions in Barrett's esophagus provide enhanced acid resistance compared to normal squamous epithelium.

PMID:17932229 SUPPORT

"Barrett's esophagus (BE) is a specialized columnar epithelium (SCE) that develops as replacement for damaged squamous epithelium (SqE) in subjects with reflux disease, and as such it is apparently more acid resistant than SqE."

This describes Barrett's esophagus as a metaplastic adaptation that develops in response to chronic reflux-induced damage and provides greater acid resistance.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

5

Digestive 2

Regurgitation VERY_FREQUENT Gastroesophageal reflux HP:0002020

Dysphagia OCCASIONAL HP:0002015

May indicate stricture or Barrett's

Respiratory 1

Chronic Cough OCCASIONAL HP:0012735

Extraesophageal manifestation

Voice 1

Hoarse Voice OCCASIONAL HP:0001609

Extraesophageal manifestation

Constitutional 1

Heartburn VERY_FREQUENT Dyspepsia HP:0410281

🧬

Genetic Associations

2

FOXF1 (Risk Factor)

Gene: FOXF1 hgnc:3809

MHC region (Risk Factor)

💊

Medical Actions

7

Proton Pump Inhibitors

Action: proton pump inhibitor pharmacotherapy Ontology label: Pharmacotherapy NCIT:C15986

First-line therapy (omeprazole, esomeprazole, pantoprazole).

Show evidence (1 reference)

PMID:34807007 SUPPORT Other

"Although PPIs remain the medical treatment of choice for GERD, multiple publications have raised questions about adverse events, raising doubts about the safety of long-term use and increasing concern about overprescribing of PPIs."

The ACG clinical guideline affirms proton pump inhibitors as the medical treatment of choice for GERD while cautioning against overprescribing and long-term safety concerns.

H2 Receptor Antagonists

Action: H2 receptor antagonist pharmacotherapy Ontology label: Pharmacotherapy NCIT:C15986

Alternative or adjunct therapy (famotidine, ranitidine).

Antacids

Action: antacid pharmacotherapy Ontology label: Pharmacotherapy NCIT:C15986

Symptomatic relief for mild symptoms.

Lifestyle Modifications

Action: dietary and lifestyle modification Ontology label: Lifestyle Therapy NCIT:C15900

Weight loss, dietary changes, elevation of head of bed.

Fundoplication

Action: fundoplication Ontology label: Surgical Procedure NCIT:C15329

Platform: Surgery

Surgical option for refractory GERD.

LINX Device

Action: magnetic sphincter augmentation device implantation Ontology label: Surgical Procedure NCIT:C15329

Magnetic sphincter augmentation.

Na+,K+-ATPase Beta1 Gene Therapy

Action: Gene Therapy NCIT:C15238

Platform: Gene therapy

Electroporation-mediated gene delivery of Na+,K+-ATPase β1 plasmid to the esophageal mucosa to restore tight junction protein expression and barrier function. This approach addresses the underlying barrier dysfunction by upregulating claudins, ZO-1, and occludin to reduce dilated intercellular spaces and prevent further epithelial damage. This is a preclinical approach only: the published evidence is a rabbit cardiomyectomy GERD model and transfected EPC1 esophageal epithelial cells. There are no human data and no registered clinical trial, so unlike the other treatments listed here it is not clinically available.

Mechanism Target:

Tight Junction Protein Loss — Electroporation-mediated delivery of Na+,K+-ATPase β1 plasmid increases tight junction protein abundance, which in turn reduces intercellular space dilation.

Show evidence (2 references)

PMID:42562993 SUPPORT Model Organism

"DIS developed by 12 weeks in a rabbit GERD model and was reduced by 70% when the Na+,K+-ATPase β1 subunit was delivered."

In a rabbit cardiomyectomy GERD model, electroporation-mediated delivery of Na+,K+-ATPase β1 reduced dilated intercellular space width by 70%.

PMID:42562993 SUPPORT In Vitro

"Transfection of esophageal epithelial cells with plasmids expressing the Na+,K+-ATPase β1 subunit increased levels of tight junction proteins and transepithelial electrical resistance."

In cultured esophageal epithelial cells, Na+,K+-ATPase β1 overexpression increased tight junction protein expression and barrier function.

🌍

Environmental Factors

5

Hiatal Hernia

Anatomical predisposition

Show evidence (1 reference)

PMID:28258452 SUPPORT Other

"Disruption of this balance occurs most commonly due to the presence of a hiatal hernia"

Names hiatal hernia as the most common cause of failure of the antireflux barrier at the esophagogastric junction.

Smoking

Reduces LES pressure

Show evidence (1 reference)

PMID:1591872 SUPPORT Human Clinical

"smokers have chronically diminished lower esophageal sphincter (LES) pressure and that periods of smoking are associated with an increased rate of reflux events"

Directly supports the annotated mechanism — smoking lowers LES pressure and increases reflux events.

Alcohol Consumption

Relaxes LES

Show evidence (1 reference)

PMID:29195669 SUPPORT Human Clinical

"both tobacco smoking and alcohol consumption can reduce the lower oesophageal sphincter pressure, facilitating reflux"

States the LES-relaxing effect of alcohol that this exposure records. The same review classes alcohol as a trigger of reflux episodes rather than a causal factor for GERD itself.

Mechanism Target:

EXACERBATES Lower Esophageal Sphincter Dysfunction — Alcohol lowers resting lower esophageal sphincter pressure, permitting reflux episodes.

Show evidence (1 reference)

PMID:29195669 SUPPORT DIRECT Human Clinical

"both tobacco smoking and alcohol consumption can reduce the lower oesophageal sphincter pressure, facilitating reflux"

States the sphincter-pressure reduction directly. EXACERBATES rather than TRIGGERS because the same review classes alcohol as a provoker of reflux episodes rather than a cause of GERD itself.

Dietary Factors

Fatty foods, caffeine, chocolate, citrus

Show evidence (1 reference)

PMID:16682569 SUPPORT Human Clinical

"there was physiologic evidence that exposure to tobacco, alcohol, chocolate, and high-fat meals decreases lower esophageal sphincter pressure"

Supports the physiologic effect of these dietary exposures on LES pressure only; the same evidence-based review found no published evidence that dietary avoidance improves GERD outcomes.

Mechanism Target:

EXACERBATES Lower Esophageal Sphincter Dysfunction — Chocolate and high-fat meals lower resting lower esophageal sphincter pressure, permitting reflux episodes.

Show evidence (1 reference)

PMID:16682569 SUPPORT DIRECT Human Clinical

"there was physiologic evidence that exposure to tobacco, alcohol, chocolate, and high-fat meals decreases lower esophageal sphincter pressure"

Physiologic evidence that these dietary exposures decrease sphincter pressure. Scoped to the sphincter effect: the same review found no evidence that dietary avoidance improves GERD outcomes, so this edge does not assert a treatment benefit.

Medications

NSAIDs, calcium channel blockers

Show evidence (1 reference)

PMID:29199166 SUPPORT Other

"These drugs can contribute to GERD by directly causing mucosal damage, by reducing lower esophageal sphincter pressure (LESP), or by affecting esophagogastric motility"

Systematic review covering NSAIDs and calcium channel blockers among others, giving the three routes by which medications contribute to GERD.

🔬

Biochemical Markers

1

Esophageal pH (Abnormal)

Context: Increased acid exposure time on pH monitoring

📊

Related Datasets

2

Genome wide expression from esophageal biopsies of subjects with EoE-like inflammatory diseases, eosinophilic esophagitis, gastroesophageal reflux disease and healthy controls geo:GSE148381

Esophageal biopsy RNA was isolated from proximal esophageal biopsied RNA from patients with EoE-like inflammatory diseases (EoE-like esophagitis, lymphocytic esophagitis, non-specific esophagitis), patients with active EoE, patients with GERD, and unaffected healthy controls. EoE-like inflammatory disease patients were clinically active at the time when biopsies were taken. None of the patients (EoE-like inflammatory diseases, EoE, GERD and controls) were under anti-eosinophil treatment (including dietary restrictions). The quality of the RNA-seq data was assessed using fastqc v. 0.11.5 1) and RSeQC v. 2.6.4 2). The reads were mapped to the reference genome using HiSat2 v. 2.1.0 3).

human BULK RNA SEQ n=51

PMID:35094416

Identified by GEO DataSets index search for Gastroesophageal Reflux Disease (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-07-31. Title, sample count, and organism are GEO's own values.

Characterisation of the sensory phenotype of the oesophageal mucosa in gastroesophageal reflux disease geo:GSE226303

Identification of Novel Immune Cell Signature in Gastroesophageal Reflux Disease: Altered Mucosal Mast Cells and Dendritic Cell Profile. The mechanisms underlying the most troublesome symptom of gastroesophageal reflux disease (GERD), heartburn, remain incompletely understood. The pathogenesis of heartburn in GERD is likely to involve not only central mechanisms of sensitization including hypervigilance, but also multiple mucosal factors including maintenance of epithelial barrier integrity via tight junction proteins, expression of acid-sensing ion channels on nerve endings, and mucosal inflammation .

human BULK RNA SEQ n=46

PMID:38098488

Identified by GEO DataSets index search for Gastroesophageal Reflux Disease (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-07-31. Title, sample count, and organism are GEO's own values.

{ }

Source YAML

click to show

name: Gastroesophageal Reflux Disease
creation_date: '2025-12-18T17:01:35Z'
description: >-
  Gastroesophageal reflux disease (GERD) is a chronic condition in which retrograde
  movement of gastric contents into the esophagus produces troublesome symptoms or
  mucosal injury. The principal mechanism is incompetence of the lower esophageal
  sphincter, often via transient sphincter relaxations, compounded by impaired
  esophageal acid clearance and, in some patients, visceral hypersensitivity.
  Heartburn and regurgitation are the cardinal symptoms, and chronic acid exposure
  can lead to erosive esophagitis and Barrett's esophagus, a metaplastic adaptation
  that carries an increased risk of esophageal adenocarcinoma.
category: Complex
parents:
- Gastrointestinal Disease
disease_term:
  preferred_term: gastroesophageal reflux disease
  term:
    id: MONDO:0007186
    label: gastroesophageal reflux disease
pathophysiology:
- name: Lower Esophageal Sphincter Dysfunction
  description: >
    Transient relaxations or chronic hypotension of the LES allow
    retrograde flow of gastric contents into the esophagus. Hiatal
    hernia exacerbates sphincter incompetence.
  locations:
  - preferred_term: Lower Esophageal Sphincter
    term:
      id: UBERON:0004550
      label: gastroesophageal sphincter
  biological_processes:
  - preferred_term: Smooth Muscle Contraction
    term:
      id: GO:0006939
      label: smooth muscle contraction
  evidence:
  - reference: PMID:38177402
    reference_title: "Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis and management."
    supports: SUPPORT
    snippet: "GERD starts in the stomach, where the refluxate material is produced.
      Following the trajectory of reflux, the failure of the antireflux barrier, primarily
      the lower oesophageal sphincter and the crural diaphragm, enables the refluxate
      to reach the oesophageal lumen, triggering oesophageal or extra-oesophageal
      symptoms."
    explanation: This review describes the failure of the antireflux barrier,
      particularly the lower esophageal sphincter, as a core mechanism allowing
      refluxate to enter the esophagus and cause symptoms.
  - reference: PMID:38177402
    reference_title: "Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis and management."
    supports: SUPPORT
    snippet: "Alterations of the oesophageal mucosal integrity, such as macroscopic
      oesophagitis or microscopic changes, determine the perception of symptoms."
    explanation: Supports symptom effects of mucosal injury in GERD, but only
      indirectly supports LES dysfunction specifically.
- name: Tight Junction Protein Loss
  biological_scale: CELLULAR
  description: >
    Tight junction proteins including claudins (1, 3, 4, 18), ZO-1, and occludin
    are decreased in GERD patient biopsies, as is the Na+,K+-ATPase β1 subunit
    that supports their assembly. Loss of these apical junctional complex
    proteins is what produces the increased paracellular permeability of the
    esophageal squamous epithelium.
  locations:
  - preferred_term: Esophageal Epithelium
    term:
      id: UBERON:0001976
      label: epithelium of esophagus
  cell_types:
  - preferred_term: Esophageal Epithelial Cell
    term:
      id: CL:0002252
      label: epithelial cell of esophagus
  biological_processes:
  - preferred_term: Tight junction organization
    term:
      id: GO:0120193
      label: tight junction organization
    modifier: DECREASED
  molecular_functions:
  - preferred_term: Na+,K+-ATPase beta1 subunit activity
    term:
      id: GO:0005391
      label: P-type sodium:potassium-exchanging transporter activity
    modifier: DECREASED
  downstream:
  - target: Dilated Intercellular Spaces
    causal_link_type: DIRECT
    description: >
      Loss of apical junctional complex proteins increases paracellular
      permeability and widens the intercellular space of the squamous
      epithelium.
  evidence:
  - reference: PMID:42562993
    reference_title: "A gene therapy approach to prevent dilated intercellular space, a hallmark of gastroesophageal reflux disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "We found that tight junction proteins and the Na+,K+-ATPase β1 subunit were decreased in biopsies from patients with GERD."
    explanation: Patient biopsy analysis directly demonstrates decreased tight junction protein expression and Na+,K+-ATPase β1 reduction in GERD.
- name: Dilated Intercellular Spaces
  biological_scale: TISSUE
  description: >
    Dilated intercellular spaces (DIS) are the histological consequence of
    junctional protein loss and are an early feature of both erosive and
    nonerosive GERD. The widened space lets acid and bile refluxate penetrate
    deeper into the esophageal epithelium.
  locations:
  - preferred_term: Esophageal Epithelium
    term:
      id: UBERON:0001976
      label: epithelium of esophagus
  downstream:
  - target: Esophageal Mucosal Injury
    causal_link_type: DIRECT
    description: >
      Reflux constituents reaching the widened intercellular space injure the
      cells and drive inflammation and tissue repair.
    evidence:
    - reference: PMID:42562993
      reference_title: "A gene therapy approach to prevent dilated intercellular space, a hallmark of gastroesophageal reflux disease."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "One consequence of the reduced barrier function and increased intercellular space in the esophageal squamous epithelium is that bile acids and other reflux constituents continually bathe the cells and decrease the intercellular pH, resulting in cell injury, inflammation, and in turn, tissue repair."
      explanation: States the injury consequence of the widened intercellular space. The sentence sits in the paper's introduction as a background assertion rather than among its own results, hence OTHER.
  evidence:
  - reference: PMID:42562993
    reference_title: "A gene therapy approach to prevent dilated intercellular space, a hallmark of gastroesophageal reflux disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Dilated intercellular space (DIS) is a hallmark pathological feature of the esophageal squamous epithelium in individuals with GERD."
    explanation: Establishes DIS as a defining pathological feature of GERD. The sentence opens the paper's introduction and carries citation marker [9], so it is background attributed to an earlier study rather than a result of this paper.
- name: Esophageal Mucosal Injury
  description: >
    Gastric acid and pepsin damage esophageal epithelium, causing
    inflammation and erosions. Bile reflux in some patients adds
    to mucosal damage.
  locations:
  - preferred_term: Esophageal Mucosa
    term:
      id: UBERON:0002469
      label: esophagus mucosa
  cell_types:
  - preferred_term: Esophageal Epithelial Cell
    term:
      id: CL:0002252
      label: epithelial cell of esophagus
  evidence:
  - reference: PMID:38177402
    reference_title: "Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis and management."
    supports: SUPPORT
    snippet: "Alterations of the oesophageal mucosal integrity, such as macroscopic
      oesophagitis or microscopic changes, determine the perception of symptoms."
    explanation: This documents that refluxate exposure produces esophageal
      mucosal injury in GERD, ranging from macroscopic esophagitis to
      microscopic changes.
  - reference: PMID:38177402
    reference_title: "Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis and management."
    supports: SUPPORT
    snippet: "It is now recognized that different GERD phenotypes have different degrees
      of reflux, severity of mucosal integrity damage and type, and severity of symptoms."
    explanation: This review recognizes that mucosal integrity damage varies
      across GERD phenotypes and contributes to symptom severity.
- name: Impaired Esophageal Clearance
  description: >
    Reduced salivary neutralization, impaired peristalsis, and
    delayed acid clearance prolong mucosal exposure to refluxate.
  locations:
  - preferred_term: Esophagus
    term:
      id: UBERON:0001043
      label: esophagus
  biological_processes:
  - preferred_term: Digestion
    term:
      id: GO:0007586
      label: digestion
  evidence:
  - reference: PMID:38177402
    reference_title: "Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis and management."
    supports: SUPPORT
    snippet: "Reflux clearance mechanisms such as primary and secondary peristalsis
      and the arrival of bicarbonate-rich saliva are critical to prevent mucosal damage."
    explanation: This directly supports the role of impaired clearance
      mechanisms in prolonging refluxate exposure and increasing mucosal damage
      in GERD.
- name: Visceral Hypersensitivity
  description: >
    Some patients experience symptoms with minimal acid exposure due
    to heightened esophageal sensory perception.
  evidence:
  - reference: PMID:38177402
    reference_title: "Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis and management."
    supports: SUPPORT
    snippet: "The intensity of the symptoms is affected by peripheral and central
      neural and psychological mechanisms."
    explanation: This describes how neural mechanisms, including visceral
      hypersensitivity, affect symptom intensity in GERD patients even with
      varying degrees of acid exposure.
- name: Gut Microbiota Dysbiosis
  description: >
    Altered gut microbiota composition contributes to GERD risk through
    bidirectional causal relationships. Protective taxa include Actinobacteria
    and Methanobrevibacter, while risk taxa include Mollicutes and Tenericutes.
  locations:
  - preferred_term: Stomach
    term:
      id: UBERON:0000945
      label: stomach
  evidence:
  - reference: PMID:38449873
    reference_title: "Causal relationship between gut microbiota and risk of gastroesophageal reflux disease: a genetic correlation and bidirectional Mendelian randomization study."
    supports: SUPPORT
    snippet: "The IVW method's findings suggested protective roles against GERD for
      the Family Clostridiales Vadin BB60 group (P = 0.027), Genus Lachnospiraceae
      UCG004 (P = 0.026), Genus Methanobrevibacter (P = 0.026), and Phylum Actinobacteria
      (P = 0.019). In contrast, Class Mollicutes (P = 0.037), Genus Anaerostipes (P
      = 0.049), and Phylum Tenericutes (P = 0.024) emerged as potential GERD risk
      factors."
    explanation: This Mendelian randomization analysis suggests causal
      relationships between specific gut microbiota taxa and GERD risk,
      identifying both potentially protective and risk-associated groups.
  - reference: PMID:38449873
    reference_title: "Causal relationship between gut microbiota and risk of gastroesophageal reflux disease: a genetic correlation and bidirectional Mendelian randomization study."
    supports: SUPPORT
    snippet: "For the first time, the MR analysis indicates a genetic link between
      gut microbiota abundance changes and GERD risk. This not only substantiates
      the potential of intestinal microecological therapy for GERD, but also establishes
      a basis for advanced research into the role of intestinal microbiota in the
      etiology of GERD."
    explanation: This indicates a genetic link between gut microbiota abundance
      and GERD risk and motivates further study of microbiome-targeted
      therapeutic approaches.
- name: Barrett's Esophagus Metaplastic Adaptation
  description: >
    Chronic reflux-induced inflammation drives metaplastic transformation of
    esophageal squamous epithelium to specialized columnar epithelium with
    altered tight junction protein expression, particularly claudin-18, which
    contributes to acid resistance.
  locations:
  - preferred_term: Esophageal Epithelium
    term:
      id: UBERON:0001976
      label: epithelium of esophagus
  evidence:
  - reference: PMID:17932229
    reference_title: "Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance."
    supports: SUPPORT
    snippet: "In SCE, Cldn-18 was the most highly expressed at the mRNA level and
      this finding is paralleled by marked elevation in protein expression on immunoblots.
      In contrast in SqE, Cldn-18 was minimally expressed at the mRNA level and undetectable
      at the protein level."
    explanation: This demonstrates that Barrett's esophagus exhibits a dramatic
      shift in tight junction protein composition, with claudin-18 becoming the
      dominant protein in metaplastic epithelium.
  - reference: PMID:17932229
    reference_title: "Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance."
    supports: SUPPORT
    snippet: "We conclude that Cldn-18 is the dominant claudin in the TJ of SCE and
      propose that the change from a Cldn-18-deficient TJ in SqE to a Cldn-18-rich
      TJ in SCE contributes to the greater acid resistance of BE."
    explanation: This establishes that the claudin-18-rich tight junctions in
      Barrett's esophagus provide enhanced acid resistance compared to normal
      squamous epithelium.
  - reference: PMID:17932229
    reference_title: "Claudin-18: a dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance."
    supports: SUPPORT
    snippet: "Barrett's esophagus (BE) is a specialized columnar epithelium (SCE)
      that develops as replacement for damaged squamous epithelium (SqE) in subjects
      with reflux disease, and as such it is apparently more acid resistant than SqE."
    explanation: This describes Barrett's esophagus as a metaplastic adaptation
      that develops in response to chronic reflux-induced damage and provides
      greater acid resistance.
phenotypes:
- name: Heartburn
  category: Gastrointestinal
  frequency: VERY_FREQUENT
  diagnostic: true
  description: >-
    Heartburn is the cardinal symptom of GERD, described as a retrosternal
    burning sensation that often radiates upward from the epigastrium toward
    the throat. It results from acidic gastric refluxate contacting and
    irritating the esophageal mucosa, and is characteristically worse after
    meals and when lying down.
  phenotype_term:
    preferred_term: Heartburn
    term:
      id: HP:0410281
      label: Dyspepsia
- name: Regurgitation
  category: Gastrointestinal
  frequency: VERY_FREQUENT
  description: >-
    Regurgitation is the effortless return of gastric or esophageal contents
    into the pharynx or mouth, often perceived as a sour or bitter taste,
    without the nausea or retching that accompanies vomiting. In GERD it
    reflects failure of the antireflux barrier and is frequently exacerbated
    by bending over or recumbency.
  phenotype_term:
    preferred_term: Regurgitation
    term:
      id: HP:0002020
      label: Gastroesophageal reflux
- name: Dysphagia
  category: Gastrointestinal
  frequency: OCCASIONAL
  notes: May indicate stricture or Barrett's
  description: >-
    Dysphagia, or difficulty swallowing, in GERD typically signals a
    complication of chronic acid injury such as a peptic esophageal stricture,
    esophageal dysmotility, or underlying Barrett's esophagus. Its presence is
    an alarm feature warranting endoscopic evaluation to exclude stricture or
    malignancy.
  phenotype_term:
    preferred_term: Dysphagia
    term:
      id: HP:0002015
      label: Dysphagia
- name: Chronic Cough
  category: Respiratory
  frequency: OCCASIONAL
  notes: Extraesophageal manifestation
  description: >-
    Chronic cough is a common extraesophageal manifestation of GERD, thought
    to arise from microaspiration of refluxate into the airways and from
    vagally mediated esophagobronchial reflexes triggered by acid in the distal
    esophagus. It is frequently nonproductive and may occur in the absence of
    typical heartburn, complicating diagnosis.
  phenotype_term:
    preferred_term: Chronic Cough
    term:
      id: HP:0012735
      label: Cough
- name: Hoarse Voice
  category: ENT
  frequency: OCCASIONAL
  notes: Extraesophageal manifestation
  description: >-
    Hoarseness is an extraesophageal manifestation of GERD attributed to
    laryngopharyngeal reflux, in which gastric acid and pepsin reach the larynx
    and inflame the vocal folds and posterior glottis. The resulting reflux
    laryngitis produces a rough or breathy voice quality, often accompanied by
    throat clearing and globus sensation.
  phenotype_term:
    preferred_term: Hoarse Voice
    term:
      id: HP:0001609
      label: Hoarse voice
biochemical:
- name: Esophageal pH
  presence: Abnormal
  context: Increased acid exposure time on pH monitoring
genetic:
- name: FOXF1
  gene_term:
    preferred_term: FOXF1
    term:
      id: hgnc:3809
      label: FOXF1
  association: Risk Factor
- name: MHC region
  association: Risk Factor
  notes: Associated with Barrett's esophagus
environmental:
- name: Hiatal Hernia
  notes: Anatomical predisposition
  evidence:
  - reference: PMID:28258452
    reference_title: Pathophysiology of Gastroesophageal Reflux Disease
    supports: SUPPORT
    evidence_source: OTHER
    snippet: Disruption of this balance occurs most commonly due to the presence of
      a hiatal hernia
    explanation: Names hiatal hernia as the most common cause of failure of the antireflux
      barrier at the esophagogastric junction.
- name: Smoking
  exposure_term:
    preferred_term: exposure to tobacco smoking
    term:
      id: ECTO:6000029
      label: exposure to tobacco smoking
  notes: Reduces LES pressure
  evidence:
  - reference: PMID:1591872
    reference_title: Cigarette smoking and gastroesophageal reflux disease
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: smokers have chronically diminished lower esophageal sphincter (LES)
      pressure and that periods of smoking are associated with an increased rate of
      reflux events
    explanation: Directly supports the annotated mechanism — smoking lowers LES pressure
      and increases reflux events.
- name: Alcohol Consumption
  exposure_term:
    preferred_term: exposure to alcohol consumption
    term:
      id: ECTO:0001082
      label: exposure to alcohol consumption
  notes: Relaxes LES
  evidence:
  - reference: PMID:29195669
    reference_title: Tobacco smoking, alcohol consumption and gastro-oesophageal reflux
      disease
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: both tobacco smoking and alcohol consumption can reduce the lower oesophageal
      sphincter pressure, facilitating reflux
    explanation: States the LES-relaxing effect of alcohol that this exposure records.
      The same review classes alcohol as a trigger of reflux episodes rather than
      a causal factor for GERD itself.
  influences_mechanisms:
  - target: Lower Esophageal Sphincter Dysfunction
    environmental_effect: EXACERBATES
    causal_link_type: DIRECT
    description: Alcohol lowers resting lower esophageal sphincter pressure, permitting reflux episodes.
    evidence:
    - reference: PMID:29195669
      reference_title: "Tobacco smoking, alcohol consumption and gastro-oesophageal reflux disease"
      supports: SUPPORT
      directness: DIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: both tobacco smoking and alcohol consumption can reduce the lower oesophageal sphincter pressure, facilitating reflux
      explanation: States the sphincter-pressure reduction directly. EXACERBATES rather than TRIGGERS because the same review classes alcohol as a provoker of reflux episodes rather than a cause of GERD itself.
- name: Dietary Factors
  notes: Fatty foods, caffeine, chocolate, citrus
  evidence:
  - reference: PMID:16682569
    reference_title: "Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: there was physiologic evidence that exposure to tobacco, alcohol, chocolate,
      and high-fat meals decreases lower esophageal sphincter pressure
    explanation: Supports the physiologic effect of these dietary exposures on LES
      pressure only; the same evidence-based review found no published evidence
      that dietary avoidance improves GERD outcomes.
  influences_mechanisms:
  - target: Lower Esophageal Sphincter Dysfunction
    environmental_effect: EXACERBATES
    causal_link_type: DIRECT
    description: Chocolate and high-fat meals lower resting lower esophageal sphincter pressure, permitting reflux episodes.
    evidence:
    - reference: PMID:16682569
      reference_title: "Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach"
      supports: SUPPORT
      directness: DIRECT
      evidence_source: HUMAN_CLINICAL
      snippet: there was physiologic evidence that exposure to tobacco, alcohol, chocolate, and high-fat meals decreases lower esophageal sphincter pressure
      explanation: 'Physiologic evidence that these dietary exposures decrease sphincter pressure. Scoped to the sphincter effect: the same review found no evidence that dietary avoidance improves GERD outcomes, so this edge does not assert a treatment benefit.'
- name: Medications
  exposure_term:
    preferred_term: medication exposure
    term:
      id: ECTO:0000509
      label: exposure to drug
  notes: NSAIDs, calcium channel blockers
  evidence:
  - reference: PMID:29199166
    reference_title: Which drugs are risk factors for the development of gastroesophageal
      reflux disease?
    supports: SUPPORT
    evidence_source: OTHER
    snippet: These drugs can contribute to GERD by directly causing mucosal damage,
      by reducing lower esophageal sphincter pressure (LESP), or by affecting esophagogastric
      motility
    explanation: Systematic review covering NSAIDs and calcium channel blockers among
      others, giving the three routes by which medications contribute to GERD.
treatments:
- name: Proton Pump Inhibitors
  description: First-line therapy (omeprazole, esomeprazole, pantoprazole).
  treatment_term:
    preferred_term: proton pump inhibitor pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  evidence:
  - reference: PMID:34807007
    reference_title: "ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Although PPIs remain the medical treatment of choice for GERD, multiple publications have raised questions about adverse events, raising doubts about the safety of long-term use and increasing concern about overprescribing of PPIs."
    explanation: The ACG clinical guideline affirms proton pump inhibitors as the medical treatment of choice for GERD while cautioning against overprescribing and long-term safety concerns.
- name: H2 Receptor Antagonists
  description: Alternative or adjunct therapy (famotidine, ranitidine).
  treatment_term:
    preferred_term: H2 receptor antagonist pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
- name: Antacids
  description: Symptomatic relief for mild symptoms.
  treatment_term:
    preferred_term: antacid pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
- name: Lifestyle Modifications
  description: Weight loss, dietary changes, elevation of head of bed.
  treatment_term:
    preferred_term: dietary and lifestyle modification
    term:
      id: NCIT:C15900
      label: Lifestyle Therapy
- name: Fundoplication
  description: Surgical option for refractory GERD.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: fundoplication
    term:
      id: NCIT:C15329
      label: Surgical Procedure
- name: LINX Device
  description: Magnetic sphincter augmentation.
  treatment_term:
    preferred_term: magnetic sphincter augmentation device implantation
    term:
      id: NCIT:C15329
      label: Surgical Procedure
- name: Na+,K+-ATPase Beta1 Gene Therapy
  description: >
    Electroporation-mediated gene delivery of Na+,K+-ATPase β1 plasmid to the
    esophageal mucosa to restore tight junction protein expression and barrier
    function. This approach addresses the underlying barrier dysfunction by
    upregulating claudins, ZO-1, and occludin to reduce dilated intercellular
    spaces and prevent further epithelial damage. This is a preclinical
    approach only: the published evidence is a rabbit cardiomyectomy GERD model
    and transfected EPC1 esophageal epithelial cells. There are no human data
    and no registered clinical trial, so unlike the other treatments listed here
    it is not clinically available.
  therapeutic_modality: GENE_THERAPY
  treatment_term:
    preferred_term: Gene Therapy
    term:
      id: NCIT:C15238
      label: Gene Therapy
  target_mechanisms:
  - target: Tight Junction Protein Loss
    description: >
      Electroporation-mediated delivery of Na+,K+-ATPase β1 plasmid increases
      tight junction protein abundance, which in turn reduces intercellular
      space dilation.
  evidence:
  - reference: PMID:42562993
    reference_title: "A gene therapy approach to prevent dilated intercellular space, a hallmark of gastroesophageal reflux disease."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "DIS developed by 12 weeks in a rabbit GERD model and was reduced by 70% when the Na+,K+-ATPase β1 subunit was delivered."
    explanation: In a rabbit cardiomyectomy GERD model, electroporation-mediated delivery of Na+,K+-ATPase β1 reduced dilated intercellular space width by 70%.
  - reference: PMID:42562993
    reference_title: "A gene therapy approach to prevent dilated intercellular space, a hallmark of gastroesophageal reflux disease."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Transfection of esophageal epithelial cells with plasmids expressing the Na+,K+-ATPase β1 subunit increased levels of tight junction proteins and transepithelial electrical resistance."
    explanation: In cultured esophageal epithelial cells, Na+,K+-ATPase β1 overexpression increased tight junction protein expression and barrier function.
  notes: >
    Preclinical. Evidence is limited to a rabbit GERD model and cultured
    esophageal epithelial cells (PMID:42562993); no human studies or trial
    registrations exist as of this curation.
classifications:
  harrisons_chapter:
  - classification_value: GASTROINTESTINAL
datasets:
- accession: geo:GSE148381
  title: Genome wide expression from esophageal biopsies of subjects with EoE-like inflammatory diseases, eosinophilic esophagitis, gastroesophageal reflux disease and healthy controls
  description: Esophageal biopsy RNA was isolated from proximal esophageal biopsied RNA from patients with EoE-like inflammatory diseases (EoE-like esophagitis, lymphocytic esophagitis, non-specific esophagitis), patients with active EoE, patients with GERD, and unaffected healthy controls. EoE-like inflammatory disease patients were clinically active at the time when biopsies were taken. None of the patients (EoE-like inflammatory diseases, EoE, GERD and controls) were under anti-eosinophil treatment (including dietary restrictions). The quality of the RNA-seq data was assessed using fastqc v. 0.11.5 1) and RSeQC v. 2.6.4 2). The reads were mapped to the reference genome using HiSat2 v. 2.1.0 3).
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  data_type: BULK_RNA_SEQ
  sample_count: 51
  publication: PMID:35094416
  notes: Identified by GEO DataSets index search for Gastroesophageal Reflux Disease (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-07-31. Title, sample count, and organism are GEO's own values.
- accession: geo:GSE226303
  title: Characterisation of the sensory phenotype of the oesophageal mucosa in gastroesophageal reflux disease
  description: 'Identification of Novel Immune Cell Signature in Gastroesophageal Reflux Disease: Altered Mucosal Mast Cells and Dendritic Cell Profile. The mechanisms underlying the most troublesome symptom of gastroesophageal reflux disease (GERD), heartburn, remain incompletely understood. The pathogenesis of heartburn in GERD is likely to involve not only central mechanisms of sensitization including hypervigilance, but also multiple mucosal factors including maintenance of epithelial barrier integrity via tight junction proteins, expression of acid-sensing ion channels on nerve endings, and mucosal inflammation .'
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  data_type: BULK_RNA_SEQ
  sample_count: 46
  publication: PMID:38098488
  notes: Identified by GEO DataSets index search for Gastroesophageal Reflux Disease (scripts/discover_datasets.py); accession and metadata verified against NCBI E-utilities on 2026-07-31. Title, sample count, and organism are GEO's own values.
references:
- reference: DOI:10.1007/s00535-023-02065-9
  title: Mucosal neuroimmune mechanisms in gastro-oesophageal reflux disease
    (GORD) pathogenesis
  findings: []
- reference: DOI:10.1038/s41575-023-00883-z
  title: 'Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis
    and management'
  findings: []
- reference: DOI:10.1080/17474124.2023.2288156
  title: Noninvasive electrical neuromodulation for gastrointestinal motility
    disorders
  findings: []
- reference: DOI:10.1152/ajpgi.00158.2007
  title: "Claudin-18: a dominant tight junction protein in Barrett's esophagus and
    likely contributor to its acid resistance"
  findings: []
- reference: DOI:10.1186/s12967-024-05878-1
  title: Esophageal microbial dysbiosis impairs mucosal barrier integrity via
    toll-like receptor 2 pathway in patients with gastroesophageal reflux
    symptoms
  findings: []
- reference: DOI:10.3389/fimmu.2024.1327503
  title: 'Causal relationship between gut microbiota and risk of gastroesophageal
    reflux disease: a genetic correlation and bidirectional Mendelian randomization
    study'
  findings: []
- reference: DOI:10.3389/fimmu.2025.1629944
  title: 'Multidimensional mechanisms and therapies underlying gastroesophageal reflux
    disease: focus on immunity, signaling pathways, and the microbiota-gut-brain axis'
  findings: []
- reference: DOI:10.3390/biom14070877
  title: The Role and Function of TRPM8 in the Digestive System
  findings: []
- reference: DOI:10.3390/cancers16193305
  title: Mechanistic Insights on Microbiota-Mediated Development and Progression
    of Esophageal Cancer
  findings: []
- reference: PMID:42562993
  title: "A gene therapy approach to prevent dilated intercellular space, a hallmark of gastroesophageal reflux disease."
  findings: []

📚

References & Deep Research